other 2025 Efficacy and Safety of Oral Gonadotropin-Releasing Hormone Antagonist, Relugolix, in Endometriosis: A Meta-Analysis of Randomized Clinical Trials American journal of therapeutics ·doi:10.1097/MJT.0000000000001842